| Today's Big NewsApr 11, 2023 |
|
July 18-19, 2023 | Jersey City, NJ Hear the latest industry trends from leaders in the field, and developed with input from our esteemed advisory board, to ensure you have a sound plan for your company, brands, and yourself. Save $500 when you Register Today!
|
|
| By Gabrielle Masson Nothing good lasts forever, a sentiment that held true for private biotech financing in 2022. After two record-setting years, fundraises finally fell, dipping 24% from the highs of 2021. |
|
|
|
By Angus Liu The U.S. antitrust watchdog is taking more time to review the proposed combination of Sanofi and Provention Bio, two diabetes drug developers. Meanwhile, all eyes in biopharma are on the merger between Pfizer and Seagen. |
By Andrea Park Elizabeth Holmes must report to prison at the end of this month as previously scheduled, the judge in her case ruled this week, shutting down the disgraced Theranos founder’s bid to delay her sentence while she appeals her conviction. |
By James Waldron Moderna’s first seasonal flu vaccine continues to underwhelm with the mRNA giant revealing that the shot hasn’t yet been able to prove success in an interim analysis of an ongoing phase 3 trial. |
|
Thursday, April 20, 2023 | 11am ET / 8am PT In this presentation, we highlight key study design challenges and considerations for rare disease CGT trials and discuss the potential for leveraging in silico approaches for generating synthetic control arms that enable a control-based comparative assessment of efficacy. Register now.
|
|
By Zoey Becker After a round of layoffs last year, Biogen is axing positions once again. This time, the company is reportedly targeting employees on its multiple sclerosis team. |
By Andrea Park Glooko’s software already gives people with diabetes a single place to pool all of the data from their health-tracking devices, and, now, it’s taking a more active role in helping manage their diabetes. |
By Max Bayer After more than 25 years, Ferring Pharmaceuticals suddenly shuttered a San Diego research institute in March just months after finishing a major renovation. It's all part of the plan, says Chief Scientific Officer Armin Metzger, Ph.D. |
By Conor Hale The Prevue II system offers a look under the skin during IV placement and provides visible markers showing the depth of the needle in real time. |
By Gabrielle Masson GSK is paying Adaptimmune £30 million ($37.3 million) to wipe its hands of two programs, one of which includes lete-cel, an asset the U.K. pharma at one point touted as its leading cell therapy. |
By Angus Liu Novartis and UCB are preparing to launch their biologics in an inflammatory disease area with significant unmet medical need called hidradenitis suppurativa. And according to two dermatologist opinion leaders, Novartis' Cosentyx may be the underdog here. |
By Andrea Park Kids going in for surgeries requiring anesthesia may soon breathe a little easier, thanks to a video game designed by a nurse practitioner at Cincinnati Children’s that aims to allay any pre-op jitters. |
Fierce podcastsDon't miss an episode |
| | This week on "The Top Line," we discuss how this year is chock-full of blockbuster drugs headed for the patent cliff, besides the well-known patent cliff for AbbVie's Humira. We also cover Johnson & Johnson's talc settlement offer and more of this week's top headlines. |
|
|---|
|
|
|
| Thursday, May 4, 2023 | 11am ET / 8am PT Join industry experts for this insightful webinar to learn more about enzyme inhibition studies. We’ll explore how these studies drive informed decisions for drug developers, frequently asked questions from sponsors, recommendations for achieving successful regulatory submission, and more. Register now. |
|
| WhitepaperThe preclinical hematotoxicity screening method that helps clients eliminate bad players earlier in the drug development process Sponsored by: ReachBio | The Cell Biology Experts™ |
| WhitepaperWe’ve identified four must-have tools to manage today’s scientific information chaos. How many are you utilizing? Sponsored By: CCC |
| WhitepaperHow advanced medicines commercial readiness differs and the resources needed to maximize potential. Sponsored by: Herspiegel Consulting |
| WhitepaperThis paper outlines an approach that digital health / therapeutics companies can use when developing a go-to-market strategy for the complex US market. Presented by Blue Matter, strategic consultants in the life sciences |
| WhitepaperPreparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| WhitepaperDiscover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific. Sponsored by: Catalent |
| Whitepaper As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs. Sponsored by: Catalent |
| WhitepaperFor sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| WhitepaperHow can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis. Sponsored by: Catalent Clinical Supply |
| WhitepaperPlanning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial. Sponsored by: Catalent |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| |
|
